PT KALBE FARMA TBK. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,455 IDR | +3.56% |
|
+3.56% | -9.63% |
| Apr. 01 | PT Kalbe Farma Tbk. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 20 | Nomura Adjusts Kalbe Farma’s Price Target to IDR1,850 From IDR2,500, Keeps at Buy | MT |
Evolution of the average Target Price on PT Kalbe Farma Tbk.
Price target over the last 5 years
History of analyst recommendation changes
ce6c2f61b2e1.y7SU-hREPcjyOMGGd1142Ktm3uGwjbewD-i3PIZkdTU.nJnLvWYzTIGVcpP3RG0ZqpM8v4DC-9D8fdrta9kpDXSH4NLIVQx-m4VRrg~4737b3c3e83f78d37c8870b8f2780212
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
1,455
IDR
Average target price
1,769
IDR
Spread / Average Target
+21.60%
High Price Target
2,800
IDR
Spread / Highest target
+92.44%
Low Price Target
1,550
IDR
Spread / Lowest Target
+6.53%
Consensus detail
Consensus revision (last 18 months)
Analysts covering PT Kalbe Farma Tbk.
| Nomura |
Trading Rating
Investor Rating
ESG Refinitiv
B+
EPS Revisions
- Stock Market
- Equities
- KLBF Stock
- Consensus PT Kalbe Farma Tbk.
